Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
[MRI and CSF features in neuromyelitis optica].
Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.
SPECIFIC TARGETING OF THE IL-23 RECEPTOR USING A NOVEL SMALL PEPTIDE NON-COMPETITIVE ANTAGONIST, DECREASES THE INFLAMMATORY RESPONSE.
What is Susac syndrome? - A brief review of articles.
Isolated dysphagia due to aquaporin-4 autoimmunity.
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.
Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.
Region and dynamic specificities of adult neural stem cells and oligodendrocyte precursors in myelin regeneration in the mouse brain.
Analysis of CH25H in multiple sclerosis and neuromyelitis optica.
Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells.
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
Childhood body mass index and multiple sclerosis risk: a long-term cohort study.
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
POEMS Syndrome in a Juvenile Initially Diagnosed as Treatment Resistant Chronic Inflammatory Demyelinating Polyneuropathy.
Cognitive and psychiatric comorbidities in neuromyelitis optica.
Is there any relation between chronic cerebrospinal venous insufficiency and multiple sclerosis? - a critical review.
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
Impaired functional integration in multiple sclerosis: a graph theory study.
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Pages
« first
‹ previous
…
548
549
550
551
552
553
554
555
556
…
next ›
last »